DYNAVAX TECHNOLOGIES CORP COM USD0.001 revenue for the last year amounted to 232.28 M USD, the most of which — 232.28 M USD — came from its highest performing source at the moment, Innovative Vaccines, the year earlier bringing 722.68 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought DYNAVAX TECHNOLOGIES CORP COM USD0.001 230.94 M USD, and the year before that — 133.77 M USD.